ScreenerHero

SVE Synthaverse S.A.

GPW · PL · Healthcare · Biotechnology · synthaverse.com
2.835PLN+0.53%Mkt Cap: 41.36M $P/E: —

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas i…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap41.36M USD
Enterprise Value74.87M USD
Revenue (TTM)10.69M USD
Gross Profit5.97M USD
Net Income (TTM)-5.05M USD
Revenue/Share0.57 PLN
Last Price2.835 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees214
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBMDLB00018
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-24.07
EV/Revenue7.01
P/S3.85
P/B1.76
EPS (TTM)-0.30
EPS (Forward)—
52W Range
2.60012% of range4.550
52W High4.550 PLN
52W Low2.600 PLN
Profitability
Gross Margin56.09%
Oper. Margin-5.15%
EBITDA Margin-29.10%
Profit Margin-47.45%
ROE-15.99%
ROA-6.55%
Growth
Revenue Growth1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.00M USD
CapEx (TTM)7.10M USD
FCF Margin-185.92%
FCF Yield-48.03%
Net Debt20.85M USD
Net Debt/EBITDA-6.70
Balance Sheet
Debt/Equity0.68
Current Ratio0.88
Quick Ratio0.15
Book Value/Sh1.60 PLN
Cash/Share0.04 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.57.61M
Float48.36M
Insiders43.87%
Institutions6.83%
Technical
SMA 502.925 (-3.1%)
SMA 2003.278 (-13.5%)
Beta0.03
S&P 52W Chg14.58%
Avg Vol (30d)37.49K
Avg Vol (10d)33.53K
Technical Indicators
RSI (14)41.9
MACD-0.0261
MACD Signal-0.0185
MACD Hist.-0.0076
BB Upper2.986 PLN
BB Middle2.887 PLN
BB Lower2.789 PLN
BB Width6.81%
ATR (14)0.0744 PLN
Vol Ratio (20d)0.44x